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Abstract
Macrophage colony-stimulating factor (CSF1 or M-CSF) and interleukin 34 (IL34) are secreted
cytokines that control macrophage survival and differentiation. Both act through the CSF1 recep-
tor (CSF1R), a type III transmembrane receptor tyrosine kinase. The functions of CSF1R and both
ligands are conserved in birds. We have analyzed protein-coding sequence divergence among
avian species. The intracellular tyrosine kinase domain of CSF1R was highly conserved in bird
species as in mammals but the extracellular domain of avian CSF1R was more divergent in birds
with multiple positively selected amino acids. Based upon crystal structures of the mammalian
CSF1/IL34 receptor-ligand interfaces and structure-based alignments, we identified amino acids
involved in avian receptor-ligand interactions. The contact amino acids in both CSF1 and CSF1R
diverged among avian species. Ligand-binding domain swaps between chicken and zebra finch
CSF1 confirmed the function of variants that confer species specificity on the interaction of CSF1
with CSF1R. Based upon genomic sequence analysis, we identified prevalent amino acid changes
in the extracellular domain of CSF1R even within the chicken species that distinguished com-
mercial broilers and layers and tropically adapted breeds. The rapid evolution in the extracellular
domain of avian CSF1R suggests that at least in birds this ligand-receptor interaction is subjected
to pathogen selection. We discuss this finding in the context of expression of CSF1R in antigen-
sampling and antigen-presenting cells.
K EYWORD S
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1 INTRODUCTION
Macrophage colony-stimulating factor (CSF1 or M-CSF) is a
hematopoietic growth factor that regulates the survival, prolifer-
ation, and differentiation of mononuclear phagocytes.1–3 CSF1 signals
through a type III tyrosine kinase (TK) CSF1 receptor (CSF1R, also
known asMCSFR, or c-Fms and recognized by anti-CD115 antibodies),
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in anymedium, provided
the original work is properly cited.
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which is expressed on the surface of macrophages, monocytes, and
their progenitors. Since macrophages control many aspects of tissue
regeneration, inflammation, and pathology, CSF1R signaling has been
considered a target for the development of therapeutic agonists and
antagonists (reviewed in Ref. 2). Loss-of-function (LOF) mutations in
the CSF1 and CSF1R loci in mice and rats are associated with depletion
of blood monocytes and most tissue macrophage populations. The
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phenotypic consequences differ depending on genetic background and
species but include osteopetrosis and postnatal growth retardation.4,5
Conversely, administration of CSF1 to mice, rats, or pigs produces
a monocytosis and expansion of tissue macrophage populations.6–8
In humans, gain-of-function coding mutations in CSF1R have been
associated with an autosomal-dominant human neurodegenerative
disease,9,10 while two recent studies describe recessive loss-of-
function CSF1R mutations11,12 that share skeletal abnormalities with
the mouse and rat Csf1r knockouts. Variants at the CSF1 locus are
strongly associated with Paget’s disease.13 Differences in phenotype
of Csf1r−/− mice compared to a spontaneous Csf1mutation (Csf1op/op)
mice suggested the existence of a second CSF1R ligand, which was
subsequently identified and named interleukin 34 (IL34).14 Mutation
of the Il34 locus in mice revealed a specific function in development
of subsets of tissue macrophages in skin and brain, where the gene is
most highly expressed.15 The two CSF1R ligands appear functionally
equivalent. IL34 expressed under the control of the CSF1 promoter
rescues the Csf1op/op phenotype.16 The CSF1R system of two ligands
binding to one receptor was shown to be conserved throughout verte-
brates, including birds17 and fish.18 An intronic enhancer that controls
CSF1R expression is also conserved from reptiles to mammals.19
Recombinant CSF1 administered to chicks produced a massive
expansion of blood and tissuemacrophage populations.20
Solution of the tertiary structures of mouse and human CSF1
revealed the characteristic four alpha helices with two beta sheets, a
structure shared by a large family of cytokines. The 3D structures of
human/mouse IL34 also highlighted four antiparallel alpha helices, but
with twoshorterbeta sheetspartially replacedwithanadditional three
alphahelices. Subsequent studies revealed thedistinctive structures of
the complexes between CSF1, IL34, and the receptor.21–23 The CSF1R
protein consists of five extracellular, Ig-like domains (D1-D5), a short
transmembrane domain (TM), and an intracellular TK domain. The
two N-terminal Ig-like domains (CSF1RD2-D3) mediate ligand binding
while the two extracellular Ig-like domains (CSF1RD4-D5) are involved
in receptor dimerization, which is required for downstream signaling
(reviewed in Ref. 3).
Most immune proteins are subjected to an “arms-race” between
host and pathogen and experience a strong positive selective
pressure.24,25 With some caveats,26 nonsynonymous (amino acid
altering) to synonymous substitution rate ratio (𝜔 = dN/dS) provides
a measure of natural selection at the protein level, where 𝜔 = 1,
𝜔 > 1, and 𝜔 < 1 indicate neutral evolution, purifying, and positive
selection, respectively.27 The average dN/dS ratio of annotated
immune-associated genes is up to four times higher than the genome-
wide average for protein-coding genes.24,25 Previous analysis on
limited datasets indicated that both CSF1 and CSF1R were subject
to positive selection in birds, whereas IL34 was subject mostly to
purifying selection.17
Since the original characterization of the CSF1R system in chicken
and zebra finch17 the Avian Phylogenomic Consortium28 completed
the draft genome sequences for 48 bird species, representing all
extant clades and many targeted projects since that time have further
expanded the number of partial or complete genomes to >300 and
the pool of predicted protein sequences for genes expressed in avian
immune cells. Among many applications, these data permitted a
re-evaluation of the gene content of avian genomes and global analysis
of dN/dS ratios.29 The expanded number of genomic sequences has
added greatly to the diversity of avian predicted CSF1R, CSF1, and
IL34 protein sequences. The current study takes advantage of the
multispecies genomic dataset to examine the contrasting evolutionary
constraints on the CSF1R system in birds andmammals.
2 MATERIALS AND METHODS
2.1 Sequence collection andmultiple
sequence alignment
Avian CSF1, IL34, and CSF1R protein and gene sequences were
retrieved from the National Centre for Biotechnology Information
(NCBI; http://ncbi.nlm.nih.gov) and completed avian genomes were
analyzed by Avian Phylogenetic Consortium.28 Accession numbers for
all protein sequences are provided in Supplementary Table 4.
2.2 Structural modeling
3D models of chCSF1, IL34, and CSF1R were created using YASARA
program. Mouse CSF1 (pdb 3ejj-a) and human IL34 and CSF1R struc-
tures (pdb 4dkd-a and 4dkd-c) were used as templates for homology
modeling. Next, avian models were compared with their mammalian
equivalents using MUltiple STructural AligNment AlGorithm (MUS-
TANG) program. Ligand docking was performed using Autodock pro-
vided by YASARA.
2.3 Phylogenetic analysis
An MSA for avian sequences was created using CLUSTALW and phy-
logenetic analysis generated by nearest neighbor joining (MacVec-
tor, Inc, www.macvector.com). Estimation of the 𝜔 rates of dN/dS
amino acid substitution in avian CSF1, IL34, and CSF1R proteins was
conducted using PAML v. 4.5 (Phylogenetic Analysis using Maximum
Likelihood; http://abacus.gene.ucl.ac.uk/software/paml.html). For the
CSF1R codon sequences, we ran the Fast Unconstrained Bayesian
AppRoximation (FUBAR) module to estimate the dN/dS ratios for indi-
vidual codons using default significance levels (HyPhy package via dat-
amonkey.org). Further details of this analysis are provided in Ref. 30.
2.4 Searching for protein coding variants in CSF1R,
CSF1, and IL34 genes in commercial and village
chicken populations
Sequence and variant data from a number of chicken populations—
both commercial and noncommercial village chicken populations—
were screened for the presence of protein coding variants from the
genes CSF1R, CSF1, and IL34. Variant data on commercial broilers
and layers originated from previous studies.31,32 Sequence and variant
data from a number of village chicken populations from diverse
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climatic zones in Ethiopia (27 populations, 263 individuals) andNigeria
(14 populations, 122 individuals) were also screened. Sequence data
on these African chicken populations have been generated as part of
the African Chickens Genetic Gains project (https://africacgg.net/) and
analyzed by researchers in the Centre for Tropical Livestock Genetics
and Health (www.ctlgh.org). These African chicken samples were
sequenced on the Illumina HiSeqX platform to produce paired-end
reads with 30X mean coverage. Upon checking the sequence quality
with the FastQC programme (v0.11.5), the sequence data were
mapped against the GRCg6a reference genome using BWA-mem
(v0.7.15) and variants called by applying the GATK (v3.8.0) Best
Practice Guide for Germline Short Variant Discovery pipeline (https://
software.broadinstitute.org/gatk/best-practices/workflow?id=11145).
Full annotation of thewhole genome sequences and analysis of genetic
diversity of these chicken populations will be published elsewhere.
2.5 Cross-species reactivity of recombinant chicken
CSF1 proteins on growth and differentiation of avian
BM-derivedmacrophage precursors
For each avian species examined (chicken, turkey, zebra finch, quail,
and duck), 3-week-old birds were sacrificed and BM cells were
obtained by flushing the marrow from two femurs and two tibias with
PBSusing a syringe and ablunt needle. For eachpreparation, cellswere
pelleted and resuspended in 4mL complete RPMI (supplemented with
10% heat-inactivated FCS, 2 mM L-glutamine, 100 µg/mL penicillin,
and 100 µg/mL streptomycin) containing 350 ng/mL recombinant
chicken CSF1 (chCSF1). Cells were plated in 60 mm bacteriological
plates (106 cells/mL) and incubated at 37◦C in a CO2 incubator for
8 days. After 4 days of incubation, fresh media supplemented with
chCSF1 was added. Media containing the recombinant cytokine was
exchanged every 2 days there afterwards. Biological activity was
confirmed by visual examination of the plates for the formation of
adherent macrophage cells and by harvesting and counting the cells.
Each experiment was conducted in triplicate.
2.6 Construction of chicken and zebra finch CSF1
receptor domain swapped CSF1 proteins
Four constructswere designed and synthesized byGeneArt (Life Tech-
nologies, Renfrew, UK). These synthetic DNA expression constructs
encoded either the mature 189 amino acid long peptides of chCSF1
(M1-P189) and zfCSF1 peptides or the two domain swapped con-
structs, zfCSF1 containing the predicted chicken ligand binding Site
1 residues T86 to E111 and the chCSF1 containing the zebra finch
residues K87 to N112 inclusive (note the construct includes the sig-
nal peptide and the numbering of amino acids refers to the full-length
protein). All four expression constructs contained attB flanking regions
for Gateway cloning (Life Technologies, Renfrew, UK). The “One-tube”
protocol using theGatewayBPandLRClonase II enzymemixwasused.
Constructs were first introduced into an entry vector pDONR221
and then immediately into the destination expression vector pDEST51
containing V5 and 6xHis tags. Note that 50 µL of Top10 competent
Escherichia coli was transformed with 1 µL of each construct using a
standard transformation protocol. Bacterial colonies were expanded
and DNA was extracted using EndoFree Plasmid Maxi Kit (Qiagen,
Manchester, UK).
2.7 Assay of the biological activity of chicken and
zebra finch CSF1 proteins using growth factor
dependent cells
We have previously established a bioassay for chicken CSF1 by sta-
bly transfecting the interleukin 3 (IL3)-dependent BaF3 cell line with
a chCSF1R expression plasmid.17 The transfected BaF3 cells express
chCSF1R on the cell surface33 and are able to survive and proliferate
in thepresenceof chCSF1.HEK293cellswere transfectedwithexpres-
sion plasmids for chCSF1, zfCSF1, zf_chCSF1, or ch_zfCSF1 and super-
natants were collected. BaF3/chCSF1R cells were cultured with 20%
HEK293T supernatant. A negative control had no added growth factor,
while 5% conditionedmedium fromX63Ag8-653myeloma cells carry-
ing an expression vector for IL-3 provided a positive control.17 Cells
were cultured at 2× 104 cells per well in a total volume of 100 µL com-
plete DMEM supplemented with an appropriate amount of HEK293
supernatant and grown for 48 h at 37◦C in a 96-well plate. Viable cells
were assayed as described previously.17 Ten microliters of 3-(4 5-di
methyl thiazol-2-yl)-2 5-diphenyltetrazolium) solution (final concen-
tration 1mg/mL)was added to eachwell and incubated at 37◦C for 3 h.
Then, 100 µL of solubilization solution (acid isopropanol) was added to
eachwell and the absorbance was read at 570 nm.
2.8 Production of recombinant avian CSF1 in
HEK293 cells
HEK293Tcells (AmericanTypeCultureCollection,Manassas,VA,USA)
were cultured in DMEM (Sigma–Aldrich, Dorset, UK) supplemented
with 10% HI-FCS (Sigma), 2 mM L-glutamine (Life Technologies,
Renfrew, UK), 100 µg/mL streptomycin (Life Technologies, Renfrew,
UK), 100 U/mL penicillin, and 0.1 mM nonessential amino acids (Life
Technologies, Renfrew, UK). On the day before the transfection, 0.8
× 106 cells/well in a six-well plate were plated with antibiotic-free
DMEM followed by transfection with 4 µg DNA (chCSF1_pDEST,
zfCSF1_pDEST, ch_zfCSF1_pDEST, zf_chCSF1_pDEST, or empty
pDEST51 DNA) using Lipofectamine 2000 (Life Technologies, Ren-
frew, UK). Supernatant containing secreted protein was harvested
after 48-h incubation at 37◦C with 5% CO2. Protein expression was
confirmed using antibodies against the C-terminal His tags to visualize
expressed peptides on aWestern blot.17
3 RESULTS
3.1 Sequence analysis of the CSF1 ligand-receptor
system from birds andmammals
Fromavailable genomicDNA sequences and entries inNCBIGenBank,
we were able to extract 68 CSF1R, 30 IL34, and 36 CSF1 predicted
full-length protein sequences orthologous to the functional chicken
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proteins analyzed previously.17 The relative paucity of avian CSF1
and IL34 sequences available reflects the difficulties in sequencing in
the respective genomic regions, in common with multiple other GC-
rich regions, in all avian genomes.29 In many cases, the sequences
annotated as CSF1 or IL34 in NCBI as a predicted protein were
truncated at the N terminus relative to full-length chicken and zebra
finch orthologs. Multiple sequence alignments (MSAs) of each of the
avian CSF1, IL34, and CSF1R protein-coding regions are provided
in Supplementary Table 1A–C. In mammals, the CSF1 locus encodes
multiple isoforms of the protein generated by alternative splicing.3
The longest cDNA encodes a membrane-bound precursor that is
cleaved from the cell surface by TNF-alpha converting enzyme (TACE,
ADAM17)34 to release the minimal bioactive CSF1 protein. In trans-
genic mice, this longer form of the ligand is required to fully com-
plement a CSF1 mutation and restore postnatal growth.35 Consis-
tent with previous evidence of the production of longer forms of
CSF1 mRNA in chickens,17 some avian genomes have been shown
to encode CSF1 proteins of 450–550 amino acids but such longer
sequences constitute only a small subset of the currently available
CSF1 protein sequences on NCBI GenBank. Alignment of the chicken
(XP_0154359; isoform X1) and zebra finch (ACS32142) longest CSF1
amino acid sequences with mammalian (mouse and human) pro-
teins (Fig. 1) reveals limited conservation of the bioactive peptide
between birds and mammals. Birds and mammals also encode a TM.
The short intracellular domain contains a membrane-proximal basic
region that is conserved between mammals and birds. The remainder
of the intracellular domain is also strongly conserved in birds. Simi-
lar membrane proximal basic domains are found in many membrane-
associated proteins including G protein-coupled receptors. The intra-
cellular domain may function to promote membrane trafficking from
the Golgi36 or conceivably also produce a reverse signal to the CSF1-
producing cell.37 The intervening region between the bioactive pep-
tide and membrane is longer in mammals than in birds. In common
with many proteolytic cleavage domains, the obvious conserved fea-
ture is repeated proline (P), glutamate (E), serine (S), and threonine (T)
amino acids.
At the N terminus, we also noted that there was considerable
ambiguity among predicted protein sequences in GenBank regarding
the location of the start codon and the length of the leader sequence.
For the purpose of the current analysis, we have aligned the processed
peptide containing the 160 amino acids that make up the minimal
bioactive 4-helix bundle.17 In the case of IL34, the predicted avian
proteins are all around 180 amino acids, truncated at the C-terminus
relative to predictedmammalian IL34 proteins (230–240 amino acids).
In mammals, some of the C-terminal amino acids were found to be
engaged in binding to CSF1R23 but in birds the 180 amino protein
contains the biological activity.17
As noted based upon comparison of chicken and zebra finch,17 the
avian CSF1 sequences all showed conservation of cysteines that pro-
vides a strong reference framework for the alignment (Supplementary
Table 1A). These conserved avian residues are predicted to form three
intrachain disulfide bonds coincident with the cysteines involved in
disulfide bonds in CSF1 of mammals and fish.17 In all of the avian CSF1
peptides, the cysteine responsible for the interchain disulfide bond in
mammalian CSF1 is substituted with glycine (G29 in Supplementary
Table 1A; position 63 in Fig. 1). Nevertheless, the chicken protein forms
a dimer through predicted large hydrophobic interfaces.17 Early stud-
ies indicated that the interchain disulfide in human CSF1 was abso-
lutely required for dimerization and biological activity, but this does
not appear tobe the case.38 Mutationof this cysteine (C31S, numbered
in themature CSF1 peptide without the leader sequence) did not com-
promise refolding or biological activity of recombinant human CSF1.
Based upon structural analysis, two amino acids (Q26 and M27) were
predicted to make strong contributions to dimer formation.38 These
are conserved in all bird andmammalianCSF1 sequences (Q25/M26 in
the activemature chicken sequence shown in Supplementary Table 1A;
positions 58/59 in Fig. 1). Indeed, D23, which made strong electro-
static and nonpolar contributions to the dimer interface in the C31S
mutant human protein, is also conserved between birds and mammals
and in all birds (Supplementary Table 1C). A second shorter segment
in CSF1 that contributed to the dimer interface, R66-N73 in human
CSF1 (positions 98–107 in Fig. 1), is also conserved betweenmammals
and birds and the core (FKENS) is identical in all bird species. A com-
bined C31S/M27R mutation produced a monomeric CSF1 that acted
as a CSF1R antagonist. The absence of cysteine in this location in the
avian ligand suggests that the C31S mutation in the mammalian pro-
tein is unlikely to be necessary to achieve this outcome. Our earlier
analysis of available CSF1 sequences indicated significant divergence
among species and evidence of positive selection.17 This conclusion
was confirmed using the larger dataset.30 Figure 2 shows a neighbor-
joining phylogenetic tree for the available sequences. This simple anal-
ysis reveals that the Galloanseriformes (chicken, turkey, guinea fowl,
quail, and goose) clearly form a separate group.
Avian IL34, unlike CSF1, is subject to purifying selection.17 Indeed,
although CSF1 is highly divergent between birds and mammals, the
core 145 amino acid chicken IL34 protein, excluding the leader
sequence, is around 60% identical to the human protein and can be
readily aligned (not shown). Despite this level of conservation, amino
acid differences among mammalian species were associated with
species-specific biological activity.39 Supplementary Table 1B shows
theMSA of the available avian IL34 proteins.
The intracellular domain of CSF1R including all of the tyrosines
that undergo phosphorylation to initiate signaling is conserved from
birds to mammals. MSA of avian CSF1R peptides reveals strong
conservation of the transmembrane and intracellular TK domains
(Supplementary Table 1C). The catalytic amino acids required for
TK activity, the tyrosine residues that are autophosphorylated in
response to receptor ligation,3 and those involved in autoinhibition
revealed by the crystal structure of the kinase domain of mammalian
CSF1R40 are conserved in all birds. This conservation is consistent
with functional studies in which the chicken CSF1R was able to signal
when expressed in mammalian growth factor-dependent cells.17 Our
previous study noted that a critical amino acid in the kinase domain,
C665 in human, is substituted with arginine in birds. This amino acid
contributes to the binding of the widely used CSF1R kinase inhibitor,
GW2580 (Patent US20040002145; 2004), which was shown to be
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F IGURE 1 Alignment of long forms of CSF1
from birds and mammals. Protein sequences of
480 amino acidCSF1 sequences fromchicken and
zebra finch and 552 amino acid sequences from
mouse and human were retrieved from NCBI.
Multiple sequence alignment was performed
using MUSCLE, in the MacVector programme.
Features discussed in the text include the signal
peptide (1–35), bioactive CSF1 peptide (35–196),
conserved cysteines (39, 80, 126, 141, 178, 186),
nonconserved mammalian-specific cysteine (63),
PEST domain (200–520), transmembrane domain
(520–542), and conserved membrane proximal
basic domain (544–552).
inactive on the chicken receptor.17 The arginine substitution is present
in all bird sequences.
The topology of CSF1R extracellular domains is conserved and the
cysteine residues in the five predicted Ig-like domains (D1–D5) in
the extracellular domain of CSF1R are present in all available bird
sequences. This provides a clear framework for structure-based align-
ment that is almost gap free (Supplementary Table 1C) and construc-
tion of a phylogenetic tree based upon the aligned sequences as shown
in Fig. 3. The tree closely resembles the recently published compre-
hensive phylogenybasedupon targetednext-generation sequencingof
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Method: Neighbor Joining; Best Tree; tie breaking = Systematic
Distance: Uncorrected ("p")
Gaps distributed proportionally
GUINEA FOWL CSF1
CHICKEN CSF1
QUAIL CSF1
TURKEY CSF1
DUCK CSF1
GOOSE CSF1
PIGEON CSF1
SWIFT CSF1
CRESTED IBIS CSF1
ADELIE PENGUIN CSF1
EMPEROR PENGUIN CSF1
BUSTARD CSF1
RUFF CSF1
BROWN ROATELO CSF1
KILLDEER CSF1
EAST AFRICAN CRANE CSF1
BALD EAGLE CSF1
GOLDEN EAGLE CSF1
BUDGERIGAR CSF1
BLUE-FRONTED AMAZON CSF1
ANNA'S HUMMINGBIRD CSF1
BLUE-CROWNED MANAKIN CSF1
GROUND FINCH CSF1
WHITE-THROATED SPARROW CSF1
AMERICAN CROW CSF1
HOODED CROW CSF1
ZEBRAFINCH CSF1
GREAT TIT CSF1
TIBETAN GROUND TIT CSF1
COLLARED FLYCATCHER CSF1
STARLING CSF1
CUCKOO CSF1
SAKER FALCON CSF1
DOWNY WOOD PECKER CSF1
BROWN KIWI CSF1
EMU CSF1
0.019
0.084
0.053
0.073
0.025
0.031
0.022
0.022
0.078
0.031
0.038
0.042
0.014
0.013
0.077
0.054
0.05
0.031
0.026
0.032
0.058
0.029
0.03
0.017
0.049
0.014
0.039
0.029
0.033
0.027
0.02
0.022
0.014
0.049
0.02
0.06
0.084
0.059
F IGURE 2 Phylogenetic analysis of CSF1 divergence among avian species.Multiple sequence alignment of the bioactive 160 amino acid CSF1
molecule was performed using ClustalW in theMacVector package to generate the alignment in Supplementary Table 1A. A neighbor joining phy-
logenetic tree was then generated using the same package.
HUME ET AL. 7
Method: Neighbor Joining; Best Tree; tie breaking = Systematic
Distance: Uncorrected ("p")
Gaps distributed proportionally
EMU CSF1R
BROWN KIWI CSF1R
OSTRICH CSF1R
GUINEA FOWL CSF1R
QUAIL CSF1R
CHICKEN CSF1R
TURKEY CSF1R
CHINESE GOOSE CSF1R
DUCK CSF1R
KILLDEER CSF1R
GOLDEN EAGLE CSF1R
BALD EAGLE CSF1R
WHITE-TAILED EAGLE CSF1R
BARN OWL CSF1R
BURROWING OWL CSF1R
EMPEROR PENGUIN CSF1R
CUCKOO ROLLER CSF1R
HOATZIN PHEASANT CSF1R
LITTLE EGRET CSF1R
WHITE-TAILED TROPIC BIRD CSF1R
CRANE CSF1R
EAST AFRICAN CRANE
CUCKOO CSF1R
RED-CRESTED TURACO CSF1R
RUFF CSF1R
BAND-TAILED PIGEON CSF1R
PIGEON CSF1R
SPECKLED MOUSEBIRD CSF1R
PEREGRINE FALCON CSF1R
SAKER FALCON CSF1R
KEA CSF1R
BLUE-FRONTED AMAZON CSF1R
BUDGERIGAR CSF1R
DOWNY WOODPECKER CSF1R
RIFLEMAN CSF1R
BLUE-CROWNED MANAKIN CSF1R
GOLDEN-CROWNED MANAKIN CSF1R
HOODED CROW CSF1R
BENGALESE FINCH CSF1R
ZEBRA FINCH CSF1R
WHITE-THROATED SPARROW CSF1R
CANARY CSF1R
GROUND FINCH CSF1R
EURASIAN BLUE TIT CSF1R
GREAT TIT CSF1R
TIBETAN GROUND TIT CSF1R
COLLARED FLYCATCHER CSF1R
STARLING CSF1R
ANNA'S HUMMINGBIRD CSF1R
SWIFT CSF1R
SERIEMA CSF1R
BROWN ROATELO CSF1R
CORMORANT CSF1R
SUNBITTERN CSF1R
CHUCK WILLS WIDOW CSF1R
IBIS CSF1R
PELICAN CSF1R
FULMAR CSF1R
SANDGROUSE CSF1R
FLAMINGO CSF1R
LOON CSF1R
BUSTARD CSF1R
CHILEAN TINAMOU CSF1R
WHITE-THROATED TINAMOU CSF1R
0.015
0.036
0.024
0.016
0.01
0.012
0.065
0.042
0.031
0.011
0.031
0.02
0.023
0.025
0.029
0.065
0.028
0.028
0.011
0.034
0.043
0.027
0.036
0.04
0.042
0.03
0.032
0.049
0.063
0.053
0.044
0.023
0.018
0.027
0.036
0.035
0.032
0.014
0.047
0.026
0.072
0.011
0.054
0.014
0.047
0.02
0.033
0.043
0.011
0.011
0.03
0.022
0.016
0.029
0.013
0.033
0.034
0.05
0.054
0.045
0.046
0.045
0.08
0.068
0.043
0.051
0.026
0.036
0.038
0.025
0.033
0.04
0.037
F IGURE 3 Phylogenetic tree analysis of CSF1R divergence
among avian species.Multiple sequence alignment of the 968 amino
acid CSF1 molecule was performed using ClustalW in the MacVec-
tor package to generate the alignment in Supplementary Table 1C.
A neighbor joining phylogenetic tree was then generated using the
same package.
a much larger assembly of avian species41 (see the phylogenetic tree
image from this study in the graphical abstract, reproduced with per-
mission) and recapitulates analysis based upon the divergence of the
conserved intronic enhancer in the CSF1R locus.19 As in the case of
CSF1, the Galloanserae form a divergent group.
The overall sequence identity between the most disparate CSF1R
protein sequences (e.g., between chicken and zebra finch), around75%,
is similar to the conservation between the most divergent mammalian
sequences (primates and rodents39) but the pattern of variation
among species is different. The majority of substitutions/insertions
among bird species occur in the region between domains 3 and 4,
and in a small number of hypervariable regions. We repeated the
dN/dS analysis using the larger dataset now available. Figure 4 shows
a comparison of the profiles for avian and mammalian CSF1R relative
to the predicted domain structures. A total of 15 amino acids showed
ɷ> 1 in the avian lineages.
3.2 Cross-species specificity of the CSF1
ligand in birds
The tertiary structures of CSF1, IL34, and CSF1R in the chicken
were modeled previously based upon published mammalian
structures. The results were consistent with strong conservation
of the tertiary structure.17 Subsequently crystal structures of
mammalian CSF1R/CSF1 and CSF1R-IL34 complexes have been
reported.21–23,42,43 In each case, ligand binding involves interaction
with two sites (Sites 1 and 2) in the Ig-like domains D2 and D3 of the
receptor. We recreated the 3D models of chCSF1, IL34, and CSF1R
and the ligand-receptor complexes using Yet Another Scientific Artifi-
cial Reality Application (YASARA) program. Mouse CSF1/CSF1R (pdb
3ejj-a) and human IL34/CSF1R structures (pdb 4dkd-a and 4dkd-c)
were used as templates for homology modeling. The avian models
were compared with their mammalian equivalents using MUltiple
STructural AligNment AlGorithm (MUSTANG) program. The modeling
results are presented in detail in Ref. 30. In overview, these analyses
confirmed that the ligand-receptor interfaces for the two ligands are
likely to be positionally conserved from birds tomammals.
Based upon the structural analyses, we predicted the candidate
Sites 1 and 2 regions of interaction for the avian CSF1/CSF1R and
IL34/CSF1R complexes. The alignments of these regions from themost
divergent chicken and zebra finch sequences and the corresponding
human sequences are provided in Table 1 and the predicted amino acid
interactions are summarized in Table 2. The binding modes clearly dif-
fer between birds andmammals. None of the positively charged amino
acids in mammalian CSF1R (human R142, R144, R146, R150, K168)
that contribute to shared interactions with CSF1 and IL34 in Site 1 on
Domain 223 is conserved in birds and the corresponding amino acids
in the predicted CSF1R structure are not conserved between zebra
finch and chicken. Strikingly, several positively selected amino acids
in Fig. 4 that fall within CSF1R domains 2 and 3 (positions 145, 147,
148, and 248 in chicken) also liewithin hypervariable regions of CSF1R
sequence divergence among avian species and impact on the contact
amino acids within both Sites 1 and 2 (Supplementary Table 1C). Site 1
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F IGURE 4 CSF1R evolutionary selection
profile.𝜔values (Y) for individual amino acids (X)
in (A) avian and (B) mammalian CSF1R, obtained
in codeml and FUBAR analyses (performed as
described in Materials and Methods section). A
line across the diagram indicates ɷ = 1 (neutral
selection). Asterisks above the graphs indicate
residues identified in FUBAR analysis as being
positively selected with a P value < 0.05. The
tertiary structure of the receptor is indicated
by the dark blue squares (Ig domains D1–D3),
light blue squares (Ig domains 4 and 5), red cir-
cle (transmembrane domain), and purple (intra-
cellular tyrosine kinase domain).
divergence also distinguishes chicken, quail, and turkey from duck and
goose. The structure-based alignment of predicted contact residues in
CSF1 reveals corresponding variation in Site 1 of the ligand, in particu-
lar multiple nonconservative substitutions between chicken T57 and
E82, whereas Site 2 on CSF1 is conserved across all available avian
sequences. The Site 1 interaction between chCSF1 and chCSF1R is
predicted to involve a salt bridge between K73 in the ligand and E168
and E170 in the receptor (Table 2). This interaction is abolished in the
zebra finch receptor (Q164, S166); substitutions shared by many bird
species (Supplementary Table 1C). Conversely, the zebra finch ligand
has two charged amino acids, E60 and E63, that are likely to form salt
bridges with R142 and K147 in chicken CSF1R (similar salt bridges
exist between CSF1 E62/D63 and CSF1R R142/R146 in the human
CSF1-CSF1R complex).
Felix et al.43 also identified the structural basis for ligand-induced
dimerization involving amino acids in Ig-like domainD4of the receptor.
In the human receptor, this interaction involves salt bridges between
R370 and E375 across the dimer interface, a mechanism that is con-
served among type III TK receptors. This region (highlighted in Sup-
plementary Table 1C) can be aligned with mammalian CSF1R and the
corresponding glutamate (E) residue is conserved across most bird
species. The precise location of basic amino acids that contribute to
dimerizationmay vary among the species.
In mammals, sequence variation in the ligand binding sites of the
CSF1/CSF1R complex constrains cross-species reactivity.39 For exam-
ple, mouse CSF1 is not active on the human CSF1R, but is active
on pig, while human and pig CSF1 are active on all three species.39
Based upon the sequence analysis and structural models, we pre-
dicted that there would also be major constraints on cross-species
reactivity of CSF1 between the most divergent species exemplified
by chicken and zebra finch. To test this hypothesis and indirectly con-
firm the accuracy of the structural model, bone marrow (BM) cells
from several avian species were treated with recombinant chicken
CSF1 (chCSF1). This system has been used before to generate bone
marrow-derived macrophages (BMDM) from the chicken for func-
tional studies. Chicken BMDM generated in response to CSF1 were
actively phagocytic, responded to lipopolysaccharide, and expressed
macrophage-specific transcripts detectable by RNAseq.17 Despite the
variation in D2 and D3 between these species, chCSF1-stimulated cell
survival and proliferation of BM cells from chicken, quail, turkey, and
also duck and gave rise to a monolayer of macrophage-like cells within
7 days. By contrast, zebra finch BM cells died when cultured with
chCSF1withnomaturemacrophage-like cells present in thewells after
7 days (not shown). To test whether the amino acid differences in Site
1 of CSF1 were sufficient to explain the species specificity, we gener-
ated expression constructs encoding chCSF1, zfCSF1, and two domain
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TABLE 1 Sequence divergence between chicken and zebra finch in the interaction sites between CSF1R and its ligands, CSF1 and IL34
CSF1
Site I
Human F55* Q58 D59 I60 M61* E62* D63* M65 R66 A74 I75* A76 V78* Q81 E82 L85*
Chicken P53 G56 T57 I58 L59 N60 R61 T63 F64 N72 K73 M74 K75 R78 K79 E82
Zebra finch P53 G56 K57 I58 L59 E60 R61 E63 F64 R72 K73 M74 Q75 R78 R79 N82
Site II
Human Y6* H9 M10 G12 S13* G14 H15 R79*
Chicken Y4 Q7 I8 T10 E11 R12 H13 R78
Zebra finch Y4 Q7 I8 T10 E11 R12 H13 R78
CSF1R-CSF1
Site I
Human Q113 E114 E119 R142 V143* R144 G145* R146 P147* L148* M149* R150 H151* K168 F169* I170* S172
Chicken F113 R114 K119 R142 N143 D144 G145 S146 K147 L148 S149 P150 G151 E168 H169 E170 K172
Zebra finch F109 R110 K115 M138 E139 N140 A141 P142 S143 L144 P145 P146 G147 Q164 N165 S166 K168
Site II
Human V229 D230 V231 N232 F233 D234 V235 Q248* Q249* S250 D251 F252 H253 N254 N255 Y257 K259 S281
Chicken P229 S230 H231 K232 Y233 D234 I235 G248 K249 P250 D251 I252 Y253 D254 G255 Y257 I259 N281
Zebra finch P225 S226 H227 K228 Y229 D230 I231 K244 M245 A246 G247 L248 E249 N250 D251 Y253 I255 N277
IL34
Site I
Human S100 E103 S104 Q106 D107 L109 E111 W116 E123 T124 L125 L127 Q131 T134
Chicken Q90 L93 H94 L96 E97 L99 E101 R106 S113 Q114 L115 D117 V121 S124
Zebra finch Q90 L93 R94 R96 E97 L99 E101 W106 C113 Q114 L115 D117 E121 S124
Site II
Human T36 F40* D43 K44 V71 E111 F72
Chicken E26 L30 D33 K34 V61 E91 L62
Zebra finch E26 L30 D33 K34 V61 E91 L62
CSF1R-IL34
Site I
Human E119 R142 V143* R144 G145* R146 P147* L148 M149* R150 H151* K168 F169 I170* S172 Q173* D174 Q176
Chicken K119 R142 N143 D144 G145 S146 K147 L148 S149 P150 G151 E168 H169 E170 K172 G173 Q174 Q176
Zebra finch K115 M138 E139 N140 A141 P142 S143 L144 P145 P146 G147 Q164 N165 S166 K168 G169 S170 R172
Site II
Human V229 D230 V231 N232 F233 D234 A245 I246 P247 Q248 Q249 S250 D251 F252 H253 N254 N255 Y257
Chicken P229 S230 H231 K232 Y233 D234 K245 S246 N247 G248 K249 P250 D251 I252 Y253 D254 G255 Y257
Zebra finch P225 S226 H227 K228 Y229 D230 K241 R242 T243 K244 M245 A246 G247 L248 E249 N250 D251 Y253
For the predicted CSF1-CSF1R interaction, the binding Sites 1 and 2 are based upon structure-based alignment of available human andmouse CSF1-CSF1R
(D1-D3) and IL34-CSF1R (D1-D3) structures. Contact amino acids in CSF1 and CSF1R derived from the human structures are highlighted in gray, and aster-
isks indicate amino acids that differ between human andmouse.Where the corresponding amino acids diverge between zebra finch and chicken, they are set
in bold.
swaps in which the variable regions of Site 1 in zebra finch CSF1 (K57-
N82) was replaced with the homologous residues in chicken CSF1
(T57-E82) (zf_chCSF1) and vice versa (in zebra finchCSF1 (ch_zfCSF1).
Four constructs were expressed in HEK293T cells and supernatants
containing recombinant CSF1 were tested. The supernatants from
HEK293 cells transfected with zfCSF1 expression plasmid were able
to promote survival of BaF3 cells expressing the chicken CSF1R to
the same extent as supernatants from cells expressing chCSF1 (Fig. 5).
Both of the domain-swapped constructs zf_chCSF1 and ch_zfCSF1
were also active on the chCSF1R reporter cell line (Fig. 5A). We
then tested the ability of each of the supernatants to promote the
differentiation of chicken BM and zebra finch BM. The zebra finch
BM cells survived and clearly differentiated to form a monolayer of
macrophage-like cells in response to zfCSF1, whereas in chCSF1 no
live cells remained in the cultures after 7 days. The domain swap in
which chCSF1 contains K57-N82 from zfCSF1 (ch_zfCSF1) was also
active on zebra finch marrow (Fig. 5B). By contrast, the reciprocal
domain swap in which the zebra finch ligand contains T57-E82 from
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TABLE 2 Amino acid interactions in the binding of chicken and zebra finch CSF1 to CSF1R
CSF1 CSF1R
Chicken Zebra finch Chicken Zebra finch
Site 1 L54 L54 S146 P142
G56 G56 S146 P142
L59 L59 S146 P142
N60 E60 R142, S146, K147, P150 M138, P142,G143, P146
T63 E63 P150 P146
K73 K73 G151, E168, E170 G145,Q164, S166
M74 M74 L148,G151, E168 P144,G147,Q164
R78 R78 S149 P145
K79 R79 H169 N165
E82 N82 E170 S166
Site 2 Q7 Q7 H231, P250 H227,A246
I8 I8 H231, Y257 H227, Y253
E11 E11 D251 G247
R12 R12 D251, I252 G247, L248
H13 H13 I252, Y257 L248, Y253
The chicken and zebra finch CSF1R complexes weremodeled based upon the humanCSF1-CSF1R (D1-D3) structure as described inMaterials andMethods
section. Non-conserved amino acids are set in bold.
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F IGURE 5 Analysis of cross-species reactivity of chicken and zebra finch (ZF) CSF1. (A) CSF1-dependent BaF3/chCSF1R cells were incu-
bated for 48 hwith supernatants from transfectedHEK293 cells expressing recombinant chCSF1, zfCSF1, or domain swap proteins zf_chCSF1 and
ch_zfCSF1 as described inMaterials andMethods section. Interleukin 3was included as a positive control and culturemedium from untransfected
HEK293 cells as a negative control. The absorbance (at 570 nm) is a measure of viable cell cells. Values are the average of three separate exper-
iments and are expressed as mean ± SD. *P < 0.05. (B) Fresh chicken (CH; at left) or ZF bone marrow cells were incubated with the same set of
HEK293 supernatants for 1 week. In both cases, no cells survived in the absence of added growth factor (panels E and J). As shown in images in
panels A–D, chicken bonemarrow cells produced a relative confluent lawn of macrophages in response to all of the supernatants. Conversely, only
zfCSF1 or zf_chCSF1 (chCSF1 with ZF Site 1) directed macrophage proliferation and differentiation from ZFmarrow (panels G and H). Images are
representative of three separate experiments.
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Site 1 of the chicken ligand (ch_zfCSF1) abolished the activity on zebra
finch marrow. This observation confirms that the difference in cross-
species reactivity between chicken and zebra finch CSF1 ligands can
be attributed to the variation in receptor binding Site 1 (Table 1).
3.3 Polymorphism in the CSF1R, CSF1, and IL34
genes among selected chicken populations
Western commercial chickens have been subject to intensive selection
of production traits: rapid growth and meat production or egg laying.
Selection has produced genomic signatures that can be detected as
extended regions of homozygosity.44 In mammals, mutations in CSF1
or CSF1R produce severe postnatal growth retardation suggesting
a link between macrophages and the growth hormone/IGF1 axis.3,5
Indeed, the CSF1R gene on chromosome 13 lies within an interval
containing signatures of selection44 and 42 separate quantitative trait
loci (QTL) (https://www.animalgenome.org/QTLdb) almost all associ-
ated with growth-related traits. We examined the impact of sequence
variants among commercial birds (Supplementary Table 2). Protein-
codingvariants affectingCSF1,CSF1R, and IL34weredetected inpedi-
gree lines of commercial broilers and layers sequenced to produce
the avian high-density SNP chip.31,32 Variants in CSF1 and IL34 were
detected with minor allele frequencies (MAF) > 0.2 in specific lines of
layers and broilers. None of the variants in CSF1 affects contact amino
acids but V45G, L54S, V121G, F124H, and L132M each alter amino
acids that are conserved across all other bird species (Supplementary
Table 1A). Although N87D is recorded as a variant in one broiler line,
all other avian sequences have an asparagine (N) in this position and
this is clearly also the common sequence in commercial birds. N87D
is predicted to be a deleterious substitution but our original chicken
CSF1 cDNA17 encodes D87 and was expressed as an active protein. In
the case of CSF1R, consistent with evidence of selective sweeps in the
genomic region, several protein-coding variants were detected with
high MAF in specific broiler or layer lines. One variant, G414S, was
universal in commercial birds (and also in African birds, below). Duck
and goose eachhave a glycine (G) in this position,whereas turkey, quail,
and guinea fowl have serine (S). So, this variant is probably a difference
distinguishing domestic chickens from red jungle fowl.
A different selection pressure including heat stress and disease
applies to indigenous chicken ecotypes selected for resilience and
survival in tropical small holder systems.45 We predicted that genes
such as CSF1 and CSF1R that diverge rapidly between species might
also exhibit functional polymorphism within a species occupying
many diverse environmental niches. We therefore explored genomic
DNA sequences from tropically adapted village chicken populations
from multiple climatically diverse regions of Ethiopia and Nigeria. The
results are shown inSupplementaryTables3.Within theCSF1Rgene in
Ethiopian birds, we identified 13 nonsynonymous protein-coding vari-
ants with prevalent allele frequencies, all but one within the extracel-
lular domain. Five of these variants were unique to the Ethiopian birds,
whereas otherswere previously assigned SNP IDs during development
of the 600,000 high-density SNP chip and have useful heterozygosity
across commercial broiler and layer lines.31,32 F125L (common to
broilers and layers); N153S, S409L, and I468L (broiler-specific); and
R294W and A308T (layer-specific) were also detected with variable
frequency in most Ethiopian and Nigerian populations, perhaps
reflecting admixture of Western birds. Among the variants shared by
commercial and tropically adapted birds, none impacted amino acids
implicated in ligand binding identified in Table 1 and most vary to
some extent between species. Position F125 is also leucine (L) in most
other avian species; position N153 is serine (S) in two species of tit,
starling, and ruff and position 308 is threonine (T) in 2manakin species
(blue-crowned and golden-crowned) and glycine (G) in cuckoo roller
(Supplementary Table 1C). Positions 294, 409, and 468 have more
than one substitution across species, including the chicken variant.
One of the novel coding variants in tropically adapted birds, D91N,
was detected in 26/27 Ethiopian populations with an average allele
frequency of 0.32 (range 0.05–0.67). The same variant was detected
in around half of the Nigerian populations with a lower MAF (aver-
age 0.08). This amino acid lies within a region of D2 that is con-
served across bird species (Supplementary Table 1C). The D to N sub-
stitution requires a single base change but that substitution is pre-
dicted in only one other species, the Kea. Accordingly, we suggest
that this change is due to some form of positive selection among
the tropically adapted chickens in Ethiopia. Only five coding variants
were detected in IL34 from African populations, of which only one,
R127Q, was prevalent in multiple Ethiopian populations (Supplemen-
tary Table 3). This amino acid is conserved in bird species but lies
outside the binding site for the receptor. In the biologically active
portionofCSF1,we identified theN87Dvariantdiscussedaboveat low
allele frequency in the majority of populations and a small number of
rare potentially deleterious variants at low frequency in specific pop-
ulations (Supplementary Table 4). None of the variants altered contact
amino acids. One other variant detected in all Ethiopian populations,
E99K, is also present in duck and goose, but not in quail or guinea fowl
reference sequences.
4 DISCUSSION
We have combined structural predictions and evolutionary analysis
based upon a large collection of avian genomic sequences to identify
selection pressure on CSF1R and its ligands in avian and mammalian
lineages. This analysis addresses a quite fundamental question. How
can the specificity of interaction between a single receptor and two
ligands be maintained through evolution in the face of pathogen
selection?We might have anticipated conservation of key amino acids
involved in ligand recognition, but where the topology of interaction is
conserved, the precise contacts have changed. Of course, the contact
amino acids would also be targeted by pathogen-associated molecules
that interfere with receptor activation. Our analysis revealed positive
selection in avian lineages of multiple amino acids that are predicted
to contribute to the recognition of CSF1 by CSF1R and corresponding
changes in the ligand. Surprisingly, despite the extensive changes
and contrary to our previous structure-based prediction,17 zfCSF1
retained the ability to activate chCSF1R,whereas chCSF1was inactive
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on zfCSF1R. Domain swap analysis confirmed that the amino acids
K57-N82within zfCSF1 (Site 1) that interactwith domainD2ofCSF1R
are both necessary and sufficient to enable activation of zebra finch
BMcells. There are six amino acid differences between the two species
in this short segment, all involving charged amino acids (Table 1). As
discussed above, we suggest that the binding affinity of chicken CSF1
for chicken CSF1R depends upon charged amino acid interactions.
By contrast, there appear to be no predicted salt-bridge interactions
in zebra finch CSF1 binding to its receptor, but two charged amino
acid substitutions may permit the formation of salt bridges to the
chicken receptor.
The analysis of many more IL34 sequences in birds (Supplementary
Table 1B) confirmed that unlike CSF1, this protein is under strong neg-
ative selection. Notwithstanding the high conservation in mammals,
human IL34 is not active on themouse CSF1R, and vice versa, but both
were equally active on pig CSF1R.39 Aside from the conserved basic
amino acid contacts that are shared with CSF1, many of the orthol-
ogous positions to the contact amino acids bound by IL34 in human
CSF1R also vary between avian species.23 Although IL34 is highly con-
served overall across avian species, the variation that does exist is
focused in several of the contact amino acids in Site 1 of IL34, and there
are corresponding changes in predicted contact amino acids in domain
2 (Site 1) of CSF1R (Supplementary Table 2). The strong negative selec-
tion acting on other parts of the IL34 sequence thus appears unrelated
to binding to CSF1R. Indeed, there is evidence for IL34 interaction
with two separate partners in mice, a protein tyrosine phosphatase46
and syndecan-1.47 The function of IL34 in birds has not been studied
beyond the demonstration that the protein is active on the chicken
CSF1R.17
The most striking feature of our analysis, which clearly dis-
tinguishes birds from mammals, is the hypervariability of the
CSF1/IL34 binding Site 1 in CSF1R. Why has selection in avian
evolution apparently acted upon ligand binding to CSF1R? One major
difference between birds and mammals lies in the expression of
CSF1R. We developed monoclonal antibodies against CSF1R33 and a
transgenic chicken line expressing reporter genes from theCSF1Rpro-
moter region.48 Combined analysis using these resources revealed the
exceptionally high level of expression of CSF1R on antigen-capturing
cells (follicle-associated epithelium [FAE]) in the bursa and lymphoid
follicles (Balic A. et al., forthcoming) and in the respiratory tract.49
These cells are unique to birds, which unlike mammals, lack lymph
nodes. They are the functional equivalent of microfold (M) cells in
mammals, the major site of luminal antigen sampling and pathogen
invasion in intestinal mucosa.50 In mammals, CSF1R is not expressed
by M cells, although CSF1R-dependent macrophages in the lamina
propria of the intestine control M cell differentiation.51 In a second
contrast with mammals, we found that CSF1R is highly expressed by
antigen-presenting dendritic cells, which are a prevalent cell popula-
tion in the avian liver in addition to their well-recognized prevalence
in bursa and spleen.52 So, we suggest two nonexclusive explanations.
One is that a class of pathogen-associated virulence determinants
acts to block binding of CSF1 or IL34 in order to compromise innate
immunity or the function of FAE. Such a pathogenicity determinant
exists in the form of the immunomodulatory BARF1 viral protein,
which binds to human CSF1R.43 A second nonexclusive explanation
is that a pathogen or pathogen-associated molecule binds to CSF1R
to enable receptor-mediated internalization. CSF1R is expressed on
the cell surface and upon ligand binding promotes endocytosis of the
ligand, either CSF1 or IL34.3 Hence CSF1R could provide a portal for
pathogen invasion.
The secondary question is how evolution in CSF1R can occur with-
out compromising the innate immune system. CSF1 and CSF1R knock-
out mutations in mice and rats4,5 are macrophage deficient and have
severe developmental abnormalities. This is also the case in zebra
fish.12 We have recently confirmed based upon CRISPR-mediated
knockout in the germ line that the chicken CSF1R is also absolutely
required for posthatch development (Balic A. and DAH, forthcoming).
Accordingly, loss of function mutations in CSF1R that abolish CSF1
binding in birds are unlikely to be tolerated as homozygotes and in the
absence of a heterozygous phenotype there would be no selection. If
CSF1R is the target of pathogen selection, only changes that preserve
ligand binding would be tolerated. Such variation may well change the
affinity of interaction with one or other ligand, but since binding is
effectively irreversible (the ligand is internalized and degraded) this
would not necessarily have any phenotypic impact. Lineage-specific
evolution of CSF1 and IL34 subsequent to receptor divergence could
occur by drift or positive selection to increase ligand binding affinity
with consequent loss of binding to ancestral forms of the receptor.
Based upon the phylogenetic tree, and the conservation of the major-
ity of the zfCSF1 ligand variants in this region across distantly related
species (kiwi, emu, emperor penguin, golden eagle), we suggest that
zfCSF1 resembles the ancestral avian CSF1 sequence and the ability
of this ancestral form of CSF1 to bind the CSF1R in chickens has been
preserved across evolution. By the same argument, CSF1 from large
animals including humans could be considered the ancestral form that
retains binding to rodent CSF1R. We have not carried out the same
functional analysis of IL34. Any pathogen that targets CSF1R would
likely impact on both CSF1 and IL34 actions. Some contact amino acids
in the receptor are shared within the hypervariable region of D2. The
alignment in SupplementaryTable1Bandanalysis inTable1 reveal that
there are corresponding changes in Site 1 of IL34. Among the avian
sequences we have analyzed, variants in Site 1 distinguish the galli-
forms (chicken, quail, and turkey) from all the other species.
Previous studies of birds in smallholder systems in Ethiopia pro-
vided strong evidence for heritable disease resistance and resilience.45
Comparative analysis of available sequences of western commer-
cial and tropically adapted populations identified prevalent protein
sequence variants (Supplementary Tables 2 and 3). Some CSF1R
variants distinguished layer and broiler lines consistent with evidence
of signatures of selection in broiler lines in this region of chromo-
some 1344 and QTL association with growth-related traits. CSF1R
is clearly highly polymorphic in chickens and the coding variants
distinguish western commercial birds from tropically adapted birds.
By contrast, the much larger exome sequence database for humans
(exac.broadinstitute.org) reveals 305 missense variants in CSF1R, but
all except H362R (MAF = 0.19) are rare (MAF < 0.01). H362 is
HUME ET AL. 13
not conserved in other mammals. Amino acid 362 lies within the
receptor dimerization domain D4. Surprisingly, the H362R variant is
strongly overrepresented (MAF 0.4) in East Asian populations and
was associated with reduced receptor dimerization and altered CSF1
responsiveness.53 Conversely, numerous synonymous coding variants
and noncoding intronic variants in human CSF1R have MAF > 0.3.
Two common variants that distinguish commercial broilers and layers,
A308T and S409L, also occur within domain 4 but whether they influ-
ence CSF1R function is unknown. Common variants detected in com-
mercial birds are relatively rare in Ethiopian and Nigerian populations
and one CSF1R variant D91N was prevalent and unique to Ethiopia
and Nigeria. Each of the variants affects an amino acid that is con-
served to some degree across avian species. Polymorphism is a com-
mon feature of innate immune receptors.54 It remains to be deter-
mined whether any of these variants can be associated with disease
resistance or production traits and could represent targets formarker-
assisted selection.
Although the focus of this study has been on the avian CSF1R sys-
tem, as mentioned in the Introduction, there is emerging interest in
CSF1R as a drug target2 and in functional analysis of loss-of-function
and gain-of-function mutations in CSF1R in human patients.9–12 The
human and mouse equivalents of the BaF3-CSF1R we have used here
to assess cross-reaction of avian CSF1 have previously used to assay
function of disease-associated humanmutant receptors.9 Our findings
in birds suggest that focused mutagenesis of the interaction sites of
CSF1with CSF1R could provide the basis for generation ofmonomeric
antagonists or higher affinity agonists.
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